Fate Therapeutics, Inc. (FATE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 116.72M |
| Enterprise Value | 147.94M |
| P/E Ratio | -1.97 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 39.68 |
| Price/Book Ratio | 1.44 |
| Enterprise/Revenue | 45.57 |
| Enterprise/EBITDA | -2.45 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -20.57 |
| Operating Margin | -22.07 |
| Return On Assets | -0.46 |
| Return On Equity | -0.59 |
| Revenue | 6.65M |
| Revenue/Share | 0.05 |
| Gross Profit | -6.26M |
| EBITDA | -127.02M |
| Net Income | -136.32M |
| Diluted EPS | -1.15 |
| Total Cash | 174.82M |
| Total Cash/Share | 1.46 |
| Total Debt | 76.79M |
| Total Debt/Equity | 0.43 |
| Current Ratio | 5.85 |
| Book Value Per Share | 1.5 |
| 52-Week Change | 88.6 |
| 52-Week High | 2.88 |
| 52-Week Low | 0.91 |
| Moving Average 50 Days | 1.87 |
| Moving Average 200 Days | 1.35 |
| Average Volume | 2.96M |
| Shares Outstanding | 116.56M |
| % Held by Institutions | 62.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |